Cellular myelocytomatosis oncogene (c-MYC); enhancer of zeste homolog 2 (Drosophila) (EZH2); MicroRNA-26a (miRNA-26a) BriefCommunication Pages: 773 - 773
Thymic stromal lymphopoietin (TSLP); TSLP receptor (TSLPR; CLRF2); IL-4; IL-13 BriefCommunication Pages: 774 - 774
Neurogenin 3 (NEUROG3); pancreatic and duodenal homeobox 1 (PDX1); v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) (MAFA) BriefCommunication Pages: 775 - 775
p53; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A; ARF) BriefCommunication Pages: 779 - 779
Regenerating islet-derived 3γ (REG3G); toll-like receptor 4 (TLR4) BriefCommunication Pages: 780 - 780
IL-8 (chemokine (C-X-C motif) ligand 8; CXCL8); peptidylarginine deiminase (PAD) BriefCommunication Pages: 781 - 781
Bioinformatics-based approach for identifying peptide inhibitors of endothelial cell proliferation and migration BriefCommunication Pages: 788 - 788
Improved enzymatic synthesis yields of cyclic echinomycin analogs in the presence of oligonucleotides BriefCommunication Pages: 789 - 789
Yeast-based assay to detect off-target effects of psychoactive compounds BriefCommunication Pages: 790 - 790